Epoetin alfa biosimilar (Probiomed)

阿法依伯汀生物类似药 (Probiomed)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Probiomed)
Drug Alias Name阿法依伯汀生物仿制药 (Probiomed)rhEPO (Probiomed)Recombinant human erythropoietin (Probiomed)Bioyetin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2006/03/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProbiomed
China Registration ClassN/A

Develop Information

Active CompaniesProbiomed
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A